MEDICINE OVERVIEW OF Jitocefpo CV 200/125 Tablet (10 Tab)

THERAPEUTIC CLASS OF Jitocefpo CV 200/125 Tablet (10 Tab)

WHY Jitocefpo CV 200/125 Tablet (10 Tab) IS PRESCRIBED

Substitutes for - Jitocefpo CV 200/125 Tablet (10 Tab)

HOW IT WORKS

HOW TO TAKE

WHEN TO TAKE

Jitocefpo CV 200/125 Tablet (10 Tab) Warnings

Precautions of Jitocefpo CV 200/125 Tablet (10 Tab)

Contraindications of Jitocefpo CV 200/125 Tablet (10 Tab)

Side Effects of Jitocefpo CV 200/125 Tablet (10 Tab)

Alcohol Interaction

Food to Avoid

Pregnancy/Lactation Protocol

Storage of Jitocefpo CV 200/125 Tablet (10 Tab)

Jitocefpo CV 200/125 Tablet (10 Tab)

Marketed By: Sastasundar Healthbuddy Ltd.
Doctor's Note Required

MRP*: Rs.580.00 60% OFF

Rs.232.00 (* Inclusive of all taxes)

₹ 23.20/Tablet (inclusive of all taxes)
Add
Loading

Jitocefpo CV 200/125 Tablet Overview:

Jitocefpo CV 200/125 Tablet is a broad-spectrum, combination antibiotic used to treat a wide variety of bacterial infections, particularly those caused by drug-resistant strains.

The medication is commonly indicated for upper and lower respiratory tract infections (such as pharyngitis, tonsillitis, bronchitis, and pneumonia), urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea.

Jitocefpo CV 200/125 Tablet is formulated with Cefpodoxime (a third-generation cephalosporin) and Clavulanic Acid (a beta-lactamase inhibitor). Cefpodoxime works by disrupting bacterial cell wall synthesis to eliminate the infection. Whereas Clavulanic Acid blocks bacterial enzymes that degrade the antibiotic, ensuring high efficacy against both Gram-positive and Gram-negative bacteria.

 

Composition:

Each film coated tablet contains- Cefpodoxime Proxetil eq. to Cefpodoxime: 200 mg and Potassium Clavulanate Diluted eq. to Clavulanic Acid: 125 mg.

Colour: Titanium Dioxide

 

Uses & Benefits of Jitocefpo CV 200/125 Tablet:

Jitocefpo CV 200/125 Tablet is prescribed for treating a wide range of bacterial infections caused by susceptible microorganisms, including:

  • Respiratory Tract Infections: Treats acute bronchitis, community-acquired pneumonia, pharyngitis, and tonsillitis.
  • Urinary Tract Infections (UTIs): Treats uncomplicated UTIs, cystitis, and kidney infections.
  • Skin & Soft Tissue Infections: Helps treat bacterial infections of the skin and soft tissues, including cellulitis, boils, abscesses, and infected wounds.
  • Sexually Transmitted Infections: Treats uncomplicated gonorrhea or anorectal gonococcal infections.

 

How Does Jitocefpo CV 200/125 Tablet Work:

The two active components of Jitocefpo CV 200/125 Tablet are Cefpodoxime and Clavulanic Acid, which work through a synergistic dual-action mechanism to fight bacterial infections.

Cefpodoxime belongs to the third-generation cephalosporin class of antibiotic, which disrupts bacterial growth by binding to penicillin-binding proteins (PBP-1 and PBP-3) in the cell membrane, thereby halting cell wall synthesis, causing the bacteria to rupture and die.

Concurrently, Clavulanic Acid acts as a beta-lactamase inhibitor by binding to and inactivating the beta-lactamase enzymes produced by resistant bacteria. This prevents the enzymatic destruction of Cefpodoxime, restoring its potency and ensuring broad-spectrum bactericidal activity against both Gram-positive and Gram-negative pathogens.

 

Dosage of Jitocefpo CV 200/125 Tablet:

  • Usage Directions

Take Jitocefpo CV 200/125 Tablet strictly according to your doctor’s instructions, following the prescribed dose and timing. Jitocefpo CV 200/125 Tablet should be swallowed whole with water and not chewed, cut, or crushed, preferably at the same time each day. Do not stop or alter the dose of Jitocefpo CV 200/125 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. If you aren't sure how to take Jitocefpo CV, check with your healthcare provider or pharmacist for instructions.

  • Missed Dose  

If you miss a dose of Jitocefpo CV 200/125 Tablet, take it as soon as you remember on the same day. If it is nearly time for your next intake, simply skip the forgotten dose and stick to your regular schedule. Do not take double doses in case if you have forgotten one.

To avoid missing doses, set reminders on your smartphone, keep drug organizer boxes, or use other audio-visual technologies to prevent missing a dose.

  • Overdose

If you accidentally take Jitocefpo CV 200/125 Tablet more than your prescribed dose, seek immediate medical advice or contact a poison control center immediately. An overdose may lead to nausea, severe diarrhea, epigastric pain, vomiting, or renal insufficiency.

 

Contraindications of Jitocefpo CV 200/125 Tablet:

Jitocefpo CV 200/125 Tablet should not be taken by individuals with a known serious allergy to Cefpodoxime, other cephalosporin antibiotics, or any component of the medicine. Patients with a history of severe allergic reactions to penicillins or other beta-lactam antibiotics should inform their doctor before treatment because cross-reactive allergic reactions can occur. The medicine should be used only when clinically appropriate and prescribed for a suspected or confirmed susceptible bacterial infection.

 

Precautions & Warnings of Jitocefpo CV 200/125 Tablet:

Before starting Jitocefpo CV 200/125 Tablet, inform your healthcare provider about your complete medical history. Caution and dosage adjustments are necessary for patients with severe liver or kidney impairment.

Extended use of Cefpodoxime may cause the overgrowth of non-susceptible organisms and can interfere with specific lab results, such as the Coombs test. Furthermore, if a severe acute hypersensitivity reaction occurs, discontinue the drug immediately, as emergency treatment with epinephrine, oxygen, intravenous fluids, airway management, and antihistamines may be required.

 

Side Effects of Jitocefpo CV 200/125 Tablet:

Like all medicines, Jitocefpo CV 200/125 Tablet can cause side effects, although not everyone will experience them. Common side effects are usually mild and manageable, including nausea, vomiting, diarrhea, abdominal pain, headache, skin rash, and vaginal fungal infection or vulvo-vaginal infections.

However, less common but serious reactions, such as kidney dysfunction, hemolytic anemia, or acute hypersensitivity (anaphylaxis, angioedema, and severe pruritus), require immediate medical attention.

 

Safety Related Concerns of Jitocefpo CV 200/125 Tablet:

  • Pregnancy

Jitocefpo CV 200/125 Tablet should be used during pregnancy only if clearly needed and specifically prescribed by a doctor. If you are pregnant, suspect you might be pregnant, or are planning to conceive, consult your physician to weigh the clinical benefits against any potential risks to the developing baby.

  • Breastfeeding

It is best to avoid using Jitocefpo CV 200/125 Tablet while breastfeeding. Since small amounts of Cefpodoxime pass into human breast milk, it could potentially affect the nursing infant. Always consult a physician to evaluate the risks and benefits before taking this medication while nursing.

  • Alcohol

It is advised to avoid alcohol consumption while taking Jitocefpo CV 200/125 Tablet. Alcohol can intensify common side effects such as nausea, vomiting, and dizziness while potentially masking symptoms of the infection and slowing your overall recovery.

  • Food Interactions

Jitocefpo CV 200/125 Tablet has no known severe interactions with specific foods. However, your physician may advise taking the medication after a meal to enhance absorption and minimize stomach upset.

Be sure to inform your healthcare provider about any known food allergies, dietary restrictions, or underlying gastrointestinal conditions before starting the medication.

  • Drug Interactions

Jitocefpo CV 200/125 Tablet can interact with several medications, altering their effectiveness or increasing the risk of adverse side effects. Co-administration with antacids or H2 receptor antagonists reduces antibiotic absorption, while probenecid decreases its renal excretion, leading to elevated blood concentration levels.

Additionally, it may increase the risk of bleeding when combined with oral anticoagulants like warfarin and can reduce the overall efficacy of oral anticholinergics.

Extreme caution is advised in patients concurrently receiving potent diuretics or other nephrotoxic agents, such as aminoglycosides, due to potential additive renal impairment.

  • Using Machinery & Driving

Jitocefpo CV 200/125 Tablet may cause dizziness, so avoid driving or operating machinery if you do not feel well.

 

Storage of Jitocefpo CV 200/125 Tablet:

Store protected from light & moisture, at a temperature not exceeding 25°C. Keep out of reach of children.

Do not take this medication after the expiration date printed on the package. It is important to dispose of expired or unused medications properly; do not throw it away casually.

 

 

Helpful Tips:

  • Taking probiotics or yogurt during or after treatment can help restore healthy gut bacteria and minimize diarrhea.
  • Drink plenty of fluids and get adequate rest to assist immune function during recovery.
  • Maintain proper hand hygiene, stay away from allergens or smoke for respiratory infections, and maintain good hydration to support urinary tract health.
  • Always complete the full course of treatment prescribed by your doctor, even if your symptoms completely disappear early. Stopping prematurely allows surviving bacteria to multiply and potentially develop antibiotic resistance.
  • Do not stop taking your medication suddenly unless your doctor specifically instructs you.
  • Do not share your medicine with someone else who has the same symptoms, as it is a prescription medication.

 

 

Frequently Asked Questions (FAQs): 

Q: What are the primary indications for Jitocefpo CV 200/125 Tablet?

A: Jitocefpo CV 200/125 Tablet is indicated for the management of multiple bacterial infections caused by susceptible organisms. These include lower or upper respiratory tract infections, urinary tract infections, skin and soft tissue infections, and uncomplicated sexually transmitted infections like gonorrhea.

 

Q: Why does Jitocefpo CV 200/125 Tablet contain two active ingredients?

A: Jitocefpo CV 200/125 Tablet contains two active ingredients because Cefpodoxime is the main antibiotic that kills target bacteria. However, some resistant bacteria produce an enzyme called beta-lactamase to destroy Cefpodoxime. Clavulanic Acid blocks this enzyme, protecting Cefpodoxime and allowing it to effectively eradicate resistant bacterial strains.

 

Q: Does Jitocefpo CV 200/125 Tablet treat common colds or the flu?

A: No, Jitocefpo CV 200/125 Tablet is an antibiotic designed specifically to fight bacterial infections. It is completely ineffective against viral infections such as the common cold, flu, or viral sore throats.

 

Q: Does Jitocefpo CV 200/125 Tablet cause diarrhea?

A: Yes, diarrhea is a common side effect of Jitocefpo CV 200/125 Tablet because broad-spectrum antibiotics alter the natural balance of beneficial gut bacteria. For mild loose stools, ensure you stay well-hydrated with fluids or ORS, and consider taking a probiotic to help restore healthy flora. However, if the diarrhea becomes severe, persistent, and watery, contains blood or mucus, or is accompanied by high fever and severe stomach cramps, contact your doctor immediately, as this may indicate a more serious condition like antibiotic-associated colitis.

 

Q: Is it safe to stop the medication once symptoms disappear?

A: No, you should never stop taking Jitocefpo CV 200/125 Tablet early, even if you feel completely better. Stopping the antibiotic prematurely can allow surviving, partially resistant bacteria to multiply, leading to a relapse of the infection that is harder to treat and contributing to antibiotic resistance. Always complete the full course as prescribed by your doctor unless specifically advised otherwise.

 

Q: Can I take probiotics with Jitocefpo CV 200/125 Tablet?

A: Yes, taking probiotics or consuming probiotic-rich foods like yogurt can be beneficial. Broad-spectrum antibiotics kill both harmful and beneficial gut bacteria, and probiotics help restore healthy gut flora to reduce the risk of antibiotic-associated diarrhea.

 

 

 

References:

1. Jitocefpo CV 200/125 Tablet. Cefpodoxime & Potassium Clavulanate Tablets. Accessed on: 28th August 2026. Click Here

2. CEFOPROX CV Tablets / Suspension. Cefpodoxime proxetil + Clavulanate potassium. Prescribing information. Last Revised: Oct 2018. Accessed on: 28th August 2026. Click Here

3. ALTIPOD CV 100 (Cefpodoxime Proxetil and Potassium Clavulanate Dispersible Tablets). Accessed on: 28th August 2026. Click Here

4. EPIPOD- CV 200. Cefpodoxime Proxitil & Potassium Clavulanate Tablet. For consumer information only. Accessed on: 28th August 2026. Click Here

5. Secoclav. Cefuroxime & Clavulanic Acid Tablet. Accessed on: 28th August 2026. Click Here

Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics and information, contained on or available through this website is for general information purposes only. SastaSundar.com makes no representation and assumes no responsibility for the accuracy of information contained on or available through this website and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this web site with other sources and review all information regarding any medical condition or treatment with your physician. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH ANY WEBSITE.

SastaSundar.com does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, procedures, treatments, opinions or other information that may be contained on or available through this website.